Time point | Screening period (data collection) | Intervention period | Follow-up period | |
---|---|---|---|---|
Weeks − 8 to 0 | Week 1–week 11 | Week12 | Week 24 | |
Enrolment | ||||
 Informed consent | × |  |  |  |
 Eligibility screen | × |  |  |  |
 Randomization | × |  |  |  |
 Allocation | × |  |  |  |
Interventions | ||||
 Acupuncture group |  | × | × |  |
 Control group |  | × | × |  |
Assessments | ||||
 AFC | × |  | × | × |
 Serum levels of FSH, LH, and E2 | × |  | × | × |
 AMH | × |  | × | × |
 Length of menstrual cycle | × |  | × | × |
 SAS score | × |  | × | × |
Safety | ||||
 Adverse events | × | × | × | × |